Peptide Libraray

AQTGTGKT

General Information

DCTPep ID DCTPep01761

Peptide Name AQTGTGKT

Sequence AQTGTGKT

Sequence Length 8

UniProt ID Not available

PubChem CID Not available

Origin Synthetics

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism CAGE protein

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C30H54N10O13

Absent amino acids CDEFHILMNPRSVWY

Theoretical pI 8.80

Acidic residues 0

Basic residues 1

Polar residues 5

Molecular weight (Average) 762.82

Molecular weight (Monoisotopic) 762.39

Common amino acids T

Net charge 1

Instability index (II) -33.7

Aliphatic index 12.50

Grand average of hydropathicity (GRAVY) -1.062

Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Should not be visible by UV spectrophotometry.

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US2018/0057532A1

Patent Title Peptide Having Eight Amino Acid Sequences Derived From Cage and Retaining Anticancer Activity and Activity to Promote Anticancer Drug Sensitivity of Anticancer Drug-Resistant Cancer Cells

Other Iinformation Patent Application; Family: 5s / 5ex; Family Jurisdictions: US, WO; Legal Status: Active; Application No: 201715624906; Filed: Jun 16, 2017; Published: Mar 1, 2018; Earliest Priority: Dec 18, 2014; Granted: Mar 26, 2019

Other Published ID US10233221B2 US10239924B2 US2018079792A1 WO2016099188A1